Cigna Dropping Coverage Of EpiPen.

reports, “CVS Health said Thursday that it would sell a generic version of an EpiPen competitor for a lower list price in a bid to tap into a groundswell of public resentment over skyrocketing drug costs, including fresh attacks by President-elect Donald Trump.” CVS said it will instead “sell the generic version of Impax Laboratories’ Adrenaclick treatment for $109.99 per two-pack before potential discounts, or about one-third the initial $300 list price of pharmaceutical giant Mylan’s new generic EpiPen.” http://www.usatoday.com/story/money/2017/01/12/cvs-health-mylan-epipen-injector-impax-adrenaclick-donald-trump/96479776/